(VIANEWS) – NASDAQ Composite ended the session with Arcturus Therapeutics (ARCT) rising 68.06% to $58.25 on Tuesday while NASDAQ Composite jumped 0.55% to $14,761.30.

Volume

Today’s last reported volume for Arcturus Therapeutics is 9720840, 1852.13% above its average volume of 497960.

Arcturus Therapeutics’s last close was $31.31, 75.86% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 34.5% for the present quarter and 321.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 289.1% and a negative 129.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $58.25 at 17:04 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way higher than its 50-day moving average of $32.51 and way above its 200-day moving average of $43.28.

More news about Arcturus Therapeutics (ARCT).

LEAVE A REPLY

Please enter your comment!
Please enter your name here